Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Antus, J. Fillinger, A. Sebe, C. Jeney, I. Horvath (Budapest, Hungary). Effect of blockade of the renin-angiotensin and endothelin systems on rat tracheal allograft rejection. Eur Respir J 2007; 30: Suppl. 51, 3128

Member's Comments

No comment yet.

Related content which might interest you: Echocardiographyc and histomorphometric assessment of the effects of pharmacological antagonism of endothelin receptors in the Sugen 5416/hypoxia rat model of pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Tissular response of transplanted cryopreserved and lyophilized tracheal allograft treated with VEGF and immunosuppression in a canine model Source: Eur Respir J 2005; 26: Suppl. 49, 177s Year: 2005 Induction of tolerance to murine tracheal allograft by intrasplenic cytotransplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Effects of AT1 receptor blockade on pulmonary and systemic manifestations in a COPD/emphysema mouse model Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009 Targeted delivery of catalase to the pulmonary endothelium preserves graft function of non-heart-beating donor lungs in pigs Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008 Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rats Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008 Protection of vasoconstriction and lung function impairment by endothelin-receptor blockers and vasoactive intestinal peptide (VIP) in isolated perfused rat lungs Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Monitoring of liver function in patients with pulmonary hypertension treated with endothelin receptor antagonists: The value of a novel monitoring system Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010 Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Endothelin-1 receptor antagonist prevents hyperoxia-induced parenchymal mechanical impairment in mice Source: Eur Respir J 2004; 24: Suppl. 48, 334s Year: 2004 Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats Source: Eur Respir J 2010; 35: 904-912 Year: 2010 Pathophysiology of the lung allograft: pathways of graft rejection Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005 Single centre experience with endothelin receptor blockade in pulmonary hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Impact of blockers of AT1 receptors to angiotensin II on endothelium vasoregulating function in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 739s Year: 2006 Severe pulmonary hypertension in chronic lung disease. Long term effects on gas exchange of endothelin receptor antagonists or PDE5 inhibitors Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Dual endothelin receptor blockade: advances in pulmonary disease Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience Year: 2008 α1-adrenoceptor antagonism does not modify the pulmonary vasoconstrictor effect of dexfenfluramine in the rat Source: Eur Respir J 2001; 18: Suppl. 33, 491s Year: 2001 Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure Source: Eur Respir J 2011; 37: 578-586 Year: 2011